share_log

康寧傑瑞製藥-B:內幕消息公告 - JSKN003在澳大利亞進行的治療HER2表達晚期實體瘤的I期臨床研究的初步結果

ALPHAMAB-B: INSIDE INFORMATION ANNOUNCEMENT - PRELIMINARY RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 IN AUSTRALIA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS

香港交易所 ·  Nov 15, 2023 23:24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more